No headlines found.
Globe Newswire (Tue, 12-Nov 7:30 AM ET)
COSCIENS Biopharma Announces Change to Board of Directors
Globe Newswire (Tue, 8-Oct 7:30 AM ET)
COSCIENS Biopharma Announces Appointment of Pierre Labb as Director
Globe Newswire (Tue, 1-Oct 5:30 PM ET)
Globe Newswire (Mon, 23-Sep 7:30 AM ET)
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
Cosciens Biopharma trades on the NASDAQ stock market under the symbol CSCI.
As of December 13, 2024, CSCI stock price was flat at $2.90 with 349 million shares trading.
CSCI has a market cap of $9.06 million. This is considered a Sub-Micro Cap stock.
CSCI support price is $2.71 and resistance is $3.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CSCI shares will trade within this expected range on the day.